114 related articles for article (PubMed ID: 9409191)
1. Granzyme B immunoreactivity in T/natural killer cell lymphomas.
Cho MS; Lee MK; Yang WI; Yoon JH
Yonsei Med J; 1997 Oct; 38(5):285-93. PubMed ID: 9409191
[TBL] [Abstract][Full Text] [Related]
2. The significance of granzyme B expression in patients with angiocentric lymphoma of the head and neck.
Kim GE; Yang WI; Lee S; Kim YB; Suh CO; Yoon JH; Oh YT; Chung HC; Kim BS
Cancer; 2001 Jun; 91(12):2343-52. PubMed ID: 11413524
[TBL] [Abstract][Full Text] [Related]
3. CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis?
Ng CS; Lo ST; Chan JK; Chan WC
Hum Pathol; 1997 Nov; 28(11):1276-82. PubMed ID: 9385933
[TBL] [Abstract][Full Text] [Related]
4. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
7. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
[TBL] [Abstract][Full Text] [Related]
8. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
Bladergroen BA; Meijer CJ; ten Berge RL; Hack CE; Muris JJ; Dukers DF; Chott A; Kazama Y; Oudejans JJ; van Berkum O; Kummer JA
Blood; 2002 Jan; 99(1):232-7. PubMed ID: 11756176
[TBL] [Abstract][Full Text] [Related]
9. Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas.
Tsang WY; Chan JK; Ng CS; Pau MY
Am J Surg Pathol; 1996 Feb; 20(2):202-10. PubMed ID: 8554110
[TBL] [Abstract][Full Text] [Related]
10. Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization.
de Bruin PC; Kummer JA; van der Valk P; van Heerde P; Kluin PM; Willemze R; Ossenkoppele GJ; Radaszkiewicz T; Meijer CJ
Blood; 1994 Dec; 84(11):3785-91. PubMed ID: 7524749
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.
Kamarashev J; Burg G; Mingari MC; Kempf W; Hofbauer G; Dummer R
Am J Pathol; 2001 May; 158(5):1593-8. PubMed ID: 11337356
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic outcome of Epstein-Barr virus positive T/NK cell lymphoma in the upper aerodigestive tract.
Hahn JS; Lee ST; Min YH; Ko YW; Yang WI; Kim GE
Yonsei Med J; 2002 Apr; 43(2):175-82. PubMed ID: 11971211
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of granzyme A and granzyme B proteases and their secretion by fresh rat natural killer cells (NK) and lymphokine-activated killer cells with NK phenotype (LAK-NK).
Velotti F; Palmieri G; D'Ambrosio D; Piccoli M; Frati L; Santoni A
Eur J Immunol; 1992 Apr; 22(4):1049-53. PubMed ID: 1551404
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.
Li T; Zhang B; Ye Y; Yin H
Hum Pathol; 2006 Jan; 37(1):54-60. PubMed ID: 16360416
[TBL] [Abstract][Full Text] [Related]
15. The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity.
Krenacs L; Smyth MJ; Bagdi E; Krenacs T; Kopper L; Rudiger T; Zettl A; Muller-Hermelink HK; Jaffe ES; Raffeld M
Blood; 2003 May; 101(9):3590-3. PubMed ID: 12506019
[TBL] [Abstract][Full Text] [Related]
16. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
17. Primary extranodal nasal-type natural killer/T-cell lymphoma of the brain: a case report.
Kaluza V; Rao DS; Said JW; de Vos S
Hum Pathol; 2006 Jun; 37(6):769-72. PubMed ID: 16733220
[TBL] [Abstract][Full Text] [Related]
18. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas.
Felgar RE; Steward KR; Cousar JB; Macon WR
Am J Pathol; 1998 Dec; 153(6):1707-15. PubMed ID: 9846961
[TBL] [Abstract][Full Text] [Related]
19. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
[TBL] [Abstract][Full Text] [Related]
20. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract.
Tai YC; Kim LH; Peh SC
Pathol Int; 2004 Mar; 54(3):158-66. PubMed ID: 14989738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]